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Using the 59 long terminal repeat (LTR) as its only promoter, the HTLV-1 provirus generates a single RNA transcript that
undergoes differential splicing to express the various viral proteins. Examination of sequence near the transcription start site
revealed an element resembling a transcriptional initiator (Inr) at position 28 to 215 in addition to the canonical TATA box
at 225. To elucidate basal control of HTLV-I gene expression, functional traits of this element were examined. It specifically
bound a protein complex, the mobility of which was altered by antibody to serum response factor, and independently
mediated reporter gene expression. Mutating the Inr in a minimal construct reduced basal transcription, whereas mutation
of the element within the context of the complete LTR left basal transcription unaffected. Presence of the element influenced
transcription start site choices. Exhibiting many characteristics of an Inr, this element may play an important role in regulating
HTLV-I gene expression in vivo, particularly during the long clinical latency period prior to development of HTLV-I-induced
disease. © 2001 Academic Press
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Human T cell leukemia virus type I (HTLV-I) is the
etiologic agent of two diseases in humans: adult T-cell
leukemia (ATL) and tropical spastic paraparesis/HTLV-I-
associated myelopathy (TSP/HAM) (Poiesz et al., 1980;
Gessain et al., 1985; Osame et al., 1987; Yoshida et al.,
1982). HTLV-I-induced disease is characterized by a long
period of clinical latency that can span two or more
decades. During this latent period, viral gene expression
is low to undetectable in infected lymphocytes.
HTLV-I encodes a transcriptional activator, Tax, which
activates both viral and cellular gene expression through
indirect association with responsive elements. Tax is,
moreover, the transforming protein of HTLV-I (Yamaoka et
al., 1992; Grassmann et al., 1989, 1992; Tanaka et al.,
1990). Because of these critical roles of Tax in viral
replication and cellular transformation, characterizing
the regulatory elements that control Tax expression is
important.
HTLV-I transcription is regulated by elements located
in the U3 region of the 59 proviral long terminal repeat
(LTR). Mechanisms of basal transcription regulation of
the LTR remain relatively undefined (Barnhart et al., 1997;
Andrews et al., 1997; Newbound et al., 1999; Kashanchi
et al., 1994). A major HTLV-I transcription start site has
been mapped (Piras et al., 1994) to ;25 bp downstream
from a consensus TATA box. Site-directed mutation of the
TATA box in the HTLV-I LTR, however, had little effect on
the basal level of viral transcription (Nicholas and Nev-
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72ins, 1991), suggesting that the HTLV-I promoter may con-
tain an element other than the TATA box that can direct
transcription.
One such element that has been identified in a variety
of promoters is an initiator, a transcription control ele-
ment capable of directing specific transcription initiation
by RNA polymerase II. Specifically, initiators can deter-
mine the transcription start site in promoters that lack a
TATA box or enhance transcription initiation in promoters
that contain a TATA box (Javahery et al., 1994). Unlike
TATA boxes, which initiate transcription ;30 bases
downstream, initiators most commonly direct transcrip-
tion from an internal residue (O’Shea-Greenfield and
Smale, 1992; Javahery et al., 1994; Lo and Smale, 1996).
We have identified a sequence within the HTLV-I LTR
that possesses sequence similarity to known Inr ele-
ments. This element is capable of both specifically bind-
ing a cellular protein and modulating activity of the viral
promoter. Based on these results we suggest that this
element is an initiator-like element, which may be used
to regulate viral gene expression under specific environ-
mental conditions.
RESULTS
The HTLV-I promoter contains a sequence similar
to an initiator element
During the long period of clinical latency, HTLV-I gene
expression is usually low to undetectable. Since expres-
sion of viral gene products such as Tax plays an impor-
tant role in the development of disease, it is necessary to
identify elements within the viral promoter that regulate
basal transcription. Visual inspection of the basal pro-
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73INITIATOR-LIKE ELEMENT IN THE HTLV-1 PROMOTERmoter region revealed a putative initiator (Inr) element
(Fig. 1A), identified on the basis of homology to the
consensus initiator sequence (Fig. 1B). Sequences of
initiator elements vary considerably, but an approximate
consensus sequence, YYCA11NT/AYY, has been identi-
ied (Bucher, 1990; Javahery et al., 1994; Lo and Smale,
996). Although the putative HTLV-I Inr contains the con-
ensus CANT sequence and downstream pyrimidines,
he upstream bases are purines. Latitude in identity of
lanking bases has been reported for Inr elements as
ong as at least some are pyrimidines (Smale et al.,
998). TATA boxes are often found ;30 bp upstream of
ellular Inr elements, whereas the HTLV-I TATA box is
nly 14 bases upstream. Located ;30 bp upstream from
he consensus initiator sequence, however, the HTLV-I
romoter does contain an AT-rich sequence that func-
ions as the poly A addition site in the 39 LTR (Fig. 1A).
oth the Inr sequence and the upstream AT-rich se-
uence are perfectly conserved between the HTLV-I and
TLV-II LTRs. These observations led us to test the
ypothesis that this Inr-like sequence might play a bio-
ogically relevant role in HTLV-I transcription regulation.
he putative HTLV-I initiator exhibits specific protein
inding
Initiator elements are thought to function in part by
inding a transcription factor and nucleating the assem-
ly of a basal transcription complex. To investigate the
bility of the putative HTLV-I Inr to bind to a cellular
rotein, an electrophoretic mobility shift assay (EMSA)
as employed using an oligonucleotide probe encom-
assing the Inr (Fig. 2A). Two prominent complexes
ormed on this probe (lane 2). Excess of the unlabeled
self” competitor reduced formation of the slower-migrat-
ng complex 1 (lane 3). An oligonucleotide containing a
FIG. 1. Sequence of the HTLV-I initiator. (A) A schematic diagram of
xamination of the region of the LTR proximal to the major transcriptio
he position of the TATA box and an upstream AT-rich sequence are ind
uthentic initiators. The HTLV-I element matches the consensus sequ-bp mutation that disrupted the crucial CA dinucleotide
f the Inr failed to compete for either complex (lane 4). To
xtend these findings, a direct binding assay was per-
ormed using the mutant Inr oligonucleotide as probe.
he specific protein complex was not observed on the
utant Inr probe (lane 6). These results demonstrate that
omplex 1 forms specifically on the Inr probe, whereas
he faster migrating complex 2 is non-specific. Using
eLa nuclear extracts fractionated on a phosphocellu-
ose column, EMSA experiments demonstrated that the
pecific complex 1 was assembled with protein from a
raction eluting at 300 mM NaCl (Fig. 2B, lane 4).
RF is part of the Inr binding complex
To examine the identity of initiator-binding proteins,
ompetition and antibody shift EMSAs were performed
Fig. 3A). The probe formed two complexes with HeLa
ell extracts (lane 2), identified as complex 1 and com-
lex 2. An unlabeled oligonucleotide containing the
TLV-I Inr wild-type sequence competed complex 1 (lane
), whereas a mutant oligonucleotide did not (lanes 3
nd 4). An oligonucleotide containing the PCNA initiator
equence failed to compete with either complex (lane 5),
uggesting that the PCNA and HTLV-I initiators have
ifferent binding specificities. Since YY1, E2F, and SRF
ave been among the proteins previously identified as
omponents of Inr binding complexes (Seto et al., 1991;
rueneberg et al., 1997), antibodies specific for these
roteins were tested for the ability to shift complex 1.
lthough YY1 antibody had no impact on the complex
lane 6), SRF antibody altered the position of complex 1,
ncreasing its mobility (lane 8). Antibody to E2F also
ailed to alter the mobility of complex 1 (data not shown).
o extend this result, the effect of SRF antibody on
hosphocellulose column fractions of HeLa extract was
the HTLV-I genome. The virus utilizes the 59 LTR as its sole promoter.
site identified an element with sequence similarity to an initiator (Inr).
(B) Sequence alignment of the putative HTLV-I Inr element with several
xcept at the two 59 terminal bases.part of
n start
icated.
ence e
74 WYCUFF, GOFF, AND MARRIOTTexamined by EMSA (Fig. 3B). Complex 1 was observed in
the 0.3 M NaCl fraction, as seen previously, and that
complex was shifted down by SRF antibody comparably
to the whole cell extract (compare lanes 2 and 3 with
lanes 6 and 7). In addition to confirming the presence of
SRF in complex 1, these results imply that there are
additional proteins in this complex and that competitive
binding of the SRF antibody displaces the SRF from the
complex.
The HTLV-I initiator is sufficient for gene expression
in a heterologous system
To determine whether the putative Inr was sufficient to
direct transcription in the absence of a TATA box, oligo-
nucleotides representing wild-type (pHILuc) or mutant
(pHImLuc) HTLV-I initiator sequences were cloned into a
luciferase reporter. The ability of these constructs to
promote luciferase expression was examined following
transfection into HeLa cells (Fig. 4A). The construct con-
taining the wild-type HTLV-I initiator (pHILuc) displayed
an approximately sixfold increase in luciferase activity
FIG. 2. Specific protein binding to the HTLV-I Inr and identification o
the protein complex that forms on the putative HTLV-I Inr element. (A) In
1–4) resulted in two complexes (lane 2). The upper complex (comple
unlabeled competitors corresponding to the wild-type Inr (lane 3) or an I
directly (lanes 5 and 6). The labeled Inr mutant probe failed to promote
and mutant Initiators are shown below. (B) To characterize the specifi
HeLa extracts were performed. The non-specific band was found in the
in the fraction eluted with 0.3 M NaCl (lane 4). The bands were not de
1.0 M NaCl (lane 6).over the promoterless parent luciferase vector (pLuc).
This activity was greater than that observed when the
PCNA initiator was tested in a similar construct (data not
shown). The initiator mutant (pHImLuc) exhibited three-
fold-reduced activity relative to the wild-type Inr con-
struct. These experiments demonstrate that the HTLV-I
Inr is sufficient as the sole promoter element to increase
reporter gene expression, presumably through transcrip-
tional activation, and that the Inr mutation that dimin-
ishes protein binding (Figs. 2A and 3) also reduces in
vivo activity. Primer extension analysis to determine di-
rectly whether elevated luciferase expression resulted
from transcriptional activation was not successful be-
cause of the low level of transcriptional activity stimu-
lated by this initiator element (data not shown).
The HTLV-I initiator is not necessary for gene
expression from the intact HTLV-I LTR
The data presented above demonstrate that the
HTLV-I Inr sequence can function independently to
confer transcriptional activity to a heterologous re-
-binding Inr mutant. Gel shift assays were performed to characterize
n of HeLa nuclear extract (lanes 2, 3, 4, and 6) with the Inr probe (lanes
t not the lower (complex 2), was specific based on competition with
nt (lane 4). A direct binding assay was performed to test the Inr mutant
ion of the specific complex 1 (lane 6). The sequences of the wild-type
lex further, gel shift assays using phosphocellulose (PC)-fractionated
n eluted with 0.5 M NaCl (lane 5), and the Inr-specific band was found
in the flow through (FT) fraction (lane 2) nor in the fraction eluted withf a non
cubatio
x 1), bu
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75INITIATOR-LIKE ELEMENT IN THE HTLV-1 PROMOTERporter construct. To determine the role of this element
in transcription control of the HTLV-I LTR, the previ-
ously described 3-bp Inr mutation was introduced into
the LTR by site-directed mutagenesis (pU3RmI). The
effects of this mutation on the transcriptional activity of
the LTR were measured by transfection and reporter
CAT assay (Fig. 4B). Basal activity of the Inr mutant
was similar to that of the wild-type LTR, indicating that
the initiator sequence is not necessary to promote
transcription within the context of the complete LTR, a
reasonable result given the large number of transcrip-
tion factor binding sites extant in the LTR and the
activated state of the cultured cells.
FIG. 4. The HTLV-I Inr is sufficient but not necessary to activate
reporter gene expression. (A) HeLa cells were transfected with pLuc,
pHILuc, or pHImLuc (1 mg per plate). Each transfection included 1 mg
of pSV b-Gal as an internal control. Luciferase assays were performed
to measure promoter activity. All results have been corrected for trans-
fection efficiency by dividing luciferase units by b-Gal units. The cor-
rected activity of pLuc was set to 1, and corrected values for pHILuc
and pHImLuc were normalized to pLuc to obtain fold activation. (B)
Basal transcription of the wild-type (pU3RCAT) and Inr mutant (pU3RmI)
LTRs was evaluated by transfection assays. Proximal promoter se-
quences of constructs are depicted above. Dotted lines indicate con-
tinued upstream LTR sequence. HeLa cells were transfected with 1 or
5 mg of reporter. Each transfection included 1 mg of pGL3Luc-Basic as
an internal control. All results have been corrected for transfection
efficiency by dividing CAT units by luciferase units. The results shown
are representative of at least three independent experiments.FIG. 3. SRF is a part of the specific Inr binding complex. (A) To establish
he identity of protein(s) in complex 1, HeLa cell extract was incubated with
he Inr probe and specific oligonucleotide competitors or antibody. Com-
lex 1 formed with HeLa cell extract (lane 2) and was competed by self
lane 3). It was not competed with the Inr mutant oligo or with the PCNA
nitiator sequence (lanes 4 and 5). YY1 antibody failed to shift the complex
r to bind the probe in the absence of cell extract (lanes 6 and 7). SRF
ntibody shifted the complex down (lane 8) and did not bind the probe in
bsence of cell extract (lane 9). (B) SRF antibody shifts the 0.3 M phos-
hocellulose fraction. HeLa cell extract fractionated over a phosphocellu-
ose column was incubated with labeled Inr probe. Complexes 1 and 2
ormed with HeLa cell extract as seen previously, and complex I was
hifted by SRF antibody as previously (lanes 2 and 3). No specific complex
as seen in the flow-through, 0.5 or 1.0 M fractions (lanes 4, 5, 8, 9, 10, and
1). Complex 1 was formed with the 0.3 M fraction (lane 6) and was shifted
own with SRF antibody (lane 7) similarly to the whole cell extract (com-
are lanes 2 and 3 to lanes 6 and 7).
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76 WYCUFF, GOFF, AND MARRIOTTExogenous SRF augments transcription
Since SRF was identified as a component of the Inr
binding complex, it was important to examine the role of
SRF in the function of the initiator in vivo. The wild-type
promoter construct was transfected into HeLa cells with
increasing concentrations of an SRF expression vector
(Fig. 5). An 11-fold increase in promoter activity was
observed upon addition of 1 mg SRF. In contrast, trans-
ection of the mutant HTLV-I LTR (pU3RmI) containing the
-bp mutation in the Inr that diminished specific complex
ormation (Fig. 2) resulted in reduced activation by SRF.
he residual SRF-induced activity of pU3RmI may result
rom other SRF responsive sites in the LTR (Pastorello
nd Marriott, unpublished results). These data suggest
hat the intact initiator element confers increased re-
ponsiveness to SRF, presumably through formation of
omplex 1 (Fig. 2).
he initiator sequence influences transcription start
ite selection
To examine the viral transcription start sites in infected
ells, RNA was isolated from the HTLV-I-infected lympho-
yte cell line, HuT-102, which contains a transcriptionally
ctive, integrated provirus. The transcription start site
as mapped using primer extension and compared to
ranscripts resulting from cells transfected with
U3RCAT or pU3RmI with or without Tax. RNA from
uT-102 cells and cells transfected with pU3RCAT plus
ax showed a similar pattern of heterogeneous start
ites around 11 and some initiation at 214 and 216 (Fig.
6, lanes 1 and 2). In the presence of Tax, transcripts
originating from pU3RmI (Inr mutation) displayed in-
creased use of start sites at 13, 15, and 16, whereas
use of the authentic 11 start site decreased (lane 3). In
the absence of Tax, pU3RCAT and pU3RmI showed ma-
jor transcript initiation at positions 11, 12, and 13 (lanes
FIG. 5. SRF augments activity of the wild-type Inr. HeLa cells were
transfected with either an HTLV-I promoter containing the wild-type Inr
sequence (pU3RCAT) or one with the 3-bp Inr mutation sequence
(pU3RmI) alone or in combination with an SRF expression plasmid (0.1
or 1 mg). Each transfection included 1 mg of pGL3-Luc control as an
internal control. Corrected CAT activity is shown as fold activation over
the CAT activity measured in the absence of SRF. At 1 mg SRF, the
wild-type promoter was about fourfold more active than the mutant
promoter. The results shown are representative of three independent
experiments.5 and 6), and pU3RmI still showed increased usage of
15 and 16 start sites (lane 6), indicating that the effect
of the Inr mutation on the transcripts originating at 15
and 16 was independent of Tax. From these results, Tax
appears to direct the minor 214 and 216 transcripts as
well as increasing the overall level of transcription. Since
pU3RmI displayed reduced initiation from the authentic
11 start site and increased use of adjacent start sites,
the Inr contributes to correct initiation. Interestingly, in a
model promoter construct containing an Inr positioned
between the TATA box and the transcription start site, as
organized in the HTLV-I LTR, no transcripts originating
within the Inr element were observed; rather the Inr
served to increase transcription at the 11 site (O’Shea-
Greenfield and Smale, 1992). The position and function of
the HTLV-I initiator recapitulates those findings within
the context of a natural promoter.
DISCUSSION
Intimation that the promoter of HTLV-I might contain an
initiator element arose first from studies showing that
mutation of the HTLV-I TATA box did not dramatically
educe levels of transcription (Nicholas and Nevins,
991) and subsequently from examination of sequence
FIG. 6. The Inr element affects transcripts near the 11 start site. RNA
was harvested from HuT-102 cells or from HeLa cells transfected with
10 mg pU3RCAT or pU3RmI, with and without 1 mg Tax. The HuT-102,
U3RCAT 1 Tax, and pU3RmI 1 Tax lanes each contained of 20 mg of
NA (lanes 1–3). The pU3RCAT and pU3RmI lanes each contained 100
mg of RNA (lanes 5 and 6). Each primer extension reaction utilized a
common radiolabeled oligonucleotide. The quality of each RNA prep-
aration was similar, as judged by agarose gel analysis (data not
shown). The sequencing reaction utilized the same oligonucleotide
primer used for primer extension allowing determination of the exact
base from which transcripts originated.
sT
i
a
C
p
c
3
t
t
p
t
i
o
r
z
S
i
w
f
p
s
i
2
b
T
e
r
G
o
d
T
a
t
t
h
r
s
c
q
a
e
t
b
f
s
c
s
w
e
p
t
o
p
L
s
P
a
P
l
(
t
(
p
77INITIATOR-LIKE ELEMENT IN THE HTLV-1 PROMOTERhomology. The putative HTLV-I Inr contains six of eight
bases present in the consensus initiator, including the
entire Inr core sequence (59-CANT-39) and the down-
tream pyrimidine residues. Although 59 flanking pyrimi-
dines are absent, it is not uncommon for functional Inrs
to vary in one or more flanking residues from consensus
(Smale et al., 1998), and the most critical residues, an A
at 11 and a T at 13 are intact in the HTLV-I LTR.
The atypical position of the putative HTLV-I initiator
may affect its properties. Most Inrs in TATA/Inr promoters
are situated 25 bases downstream of the TATA box. In
this arrangement, the two elements cooperate to direct
transcription from the same base, generally A of the Inr
CANT sequence. The putative HTLV-I Inr is positioned
between the TATA box and the TATA-directed start site.
To our knowledge, this configuration of basal elements
has not been previously reported in a natural promoter
and might recruit a collection of general transcription
factors with unique properties.
Several cellular proteins have been reported that bind
different viral Inrs, recruiting the general transcription
machinery. A general transcription factor, TFII-I, has
been shown to bind the Inr of the adenovirus major late
promoter (Roy et al., 1991, 1997). The Inr of the SV40
major late promoter binds E2F, a transcription factor
important in regulating cell cycle progression (Kraus et
al., 1996), and the Inr of the adeno-associated virus type
2 P5 promoter has been shown to bind Ying-Yang 1 (YY1),
a Kruppel-related transcriptional activator/repressor
(Seto et al., 1991; Kyostio et al., 1995). The two largest
FIID sub-units, TAF 150 and TAF 250, have also been
mplicated in transcription directed by Inrs (Kaufmann et
l., 1998; Verrijzer et al., 1995; Oelgeschlager et al., 1996;
halkley and Verrijzer, 1999). In our experiments, the
utative HTLV-I Inr element specifically binds a protein
omplex that elutes from a phosphocellulose column at
00 mM NaCl, and an SRF antibody shifts the position of
he specific protein complex in this fraction. Antibodies
o YY1 failed to affect migration of the Inr gel shift com-
lex, as did antibodies to E2F (data not shown). Although
hese results implicate SRF in the binding to the HTLV-I
nitiator element and eliminate a role for YY1 and E2F,
ther proteins remain Inr-binding candidates. In light of a
eport that TFII-I, a known initiator-binding protein (Man-
ano-Winkler et al., 1996; Roy et al., 1991) interacts with
RF (Grueneberg et al., 1997), its role will be particularly
nteresting to examine.
Transcription start sites mapped in this study from the
ild-type HTLV-I LTR integrated in HuT-102 cells and
rom transfected pU3RCAT plasmid are concordant with
revious reports. This analysis confirmed the 11 start
ite and demonstrated that Tax increases transcription
nitiation at the 11 site as well as two additional sites,
14 and 216. The 214 and 216 start sites map near the
Inr located at 213 to 28 but do not appear to be directed
y it. In a synthetic construct, addition of a Inr between a
ATA element and the TATA-directed start site resulted innhanced transcription from the TATA-directed site
ather than transcription initiation within the Inr (O’Shea-
reenfield and Smale, 1992). Our results with a naturally
ccurring sequence from the HTLV-I LTR affirm those
ata; the HTLV-I Inr-enhanced transcription from the
ATA-directed start site but did not direct initiation from
n internal site. Moreover, mutation of the Inr element in
he LTR changed the preference of start sites. By con-
ributing to correct start site positioning, the initiator may
elp insure integrity of the HTLV-I genome during viral
eplication.
It is possible that the Inr plays a role in HTLV-I tran-
cription only at specific stages of the viral life cycle. T
ells, the natural reservoir for HTLV-I, are generally in a
uiescent state in which transcription factors are limiting
nd housekeeping genes, often regulated by initiator
lements, are preferentially transcribed. In this context,
he virus may utilize the initiator-like element to launch
asal transcription. Production of the viral Tax protein
rom these initial rounds of basal transcription may allow
ubsequent activation of cellular genes, converting the
ell to an activated state and allowing direction of tran-
cription from the primary TATA box.
The results reported here have identified an element
ith a high degree of identity to a transcriptional initiator
lement. The ability of this element to bind a specific
rotein complex containing SRF and to support transcrip-
ion independently in vivo is consistent with the function
f this element as an Inr. As future studies more com-
letely dissect basal regulatory elements in the HTLV-I
TR, the role of the Inr in basal and Tax-activated tran-
cription should be clarified.
MATERIALS AND METHODS
lasmids
pU3RCAT has been previously described (Sodroski et
l., 1984). The following plasmids were purchased from
romega: pGL3-Luc Basic (a promoterless, enhancer-
ess luciferase expression plasmid), pGL3-Luc Enhancer
a promoterless luciferase expression vector that con-
ains one copy of the SV40 enhancer), pGL3-Luc Control
a luciferase expression vector under control of the SV40
romoter and enhancer), and pSV-b-galactosidase (a
b-galactosidase expression plasmid for monitoring
transfection efficiencies of mammalian cells).
The pU3RmI construct, containing a 3-bp mutation in
the putative Inr element was generated by mega-primer
site-directed mutagenesis (Barik, 1995). Briefly, a sense-
strand oligo containing the mutation (59-AAAAGCGTG-
GAGGGGGTTCAGGAGGGG-39) was used as one primer
in a PCR reaction. The anti-sense primer (59-AGTATC-
CTCGAGGACTCT-39) corresponded to a region of the
pU3RCAT plasmid backbone. PCR, using pU3RCAT as
the template, yielded a 453-bp PCR product, which was
then used as a sense-strand “mega-primer” in a second
round of PCR. This PCR reaction used an anti-sense
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78 WYCUFF, GOFF, AND MARRIOTTprimer (59-TGCCTCAAAATGTTCTTTACGATGCCATTGG-
39) corresponding to a different region of the pU3RCAT
template. The PCR product was purified, digested with
XhoI and HindIII, and cloned into pU3RCAT. The resulting
construct was sequenced to ensure that only the desired
mutation was introduced into the LTR. Inserting one of
the following oligonucleotide cassettes (sense strand
shown) into the HindIII site of pGL3-Luc Enhancer gen-
erated plasmids pHILuc and pHImLuc:
putative HTLV-I
Inr (to make
pHILuc) 59-AGCTTCTAGAGACAGTTCAGGA-39
mutated HTLV-I
Inr (to make
pHImLuc) 59-AGCTTCTAGAGGGGGTTCAGGA-39
These plasmids were sequenced to ensure that only one
copy of the element was present and that it was in the
correct orientation.
Gel shift assays
Gel shift probes were labeled with [32P]a-dCTP using a
Klenow fill-in reaction and gel purified. One nanogram of
probe was used for each gel-shift reaction. For gel shifts
using nuclear extract, the reaction also contained 1 ml of
eLa nuclear extract (6.2 mg/ml), 1 mg/ml of poly(dI/dC),
6 ml of 53 gel shift buffer [50 mM HEPES (pH 7.9), 20%
Ficoll, 250 mM KCl, 1 mM EDTA (pH 8.0), 1 mM DTT], and
18 ml of buffer D [20 mM HEPES (pH 7.9), 100 mM KCl,
2.5 mM MgCl2, 17% Glycerol, 1 mM EDTA (pH 8.0), 1 mM
DTT]. Competitor DNAs were used at 100-fold molar
excess.
Cells
HeLa cells were grown in DMEM medium supple-
mented with 10% fetal bovine serum. The human T cell
line HuT-102, which contains an integrated HTLV-I pro-
virus and produces infectious virus, was cultured in
RPMI medium supplemented with 10% fetal bovine se-
rum.
Transfections
HeLa cells were transfected by calcium phosphate
precipitation as previously described (Connor et al.,
1993), and an internal control for transfection efficiency
was always included. If the primary reporter was CAT,
the internal control was pGL3-LucControl; if the reporter
was a luciferase-based expression plasmid, the internal
control was pSV b-Gal. Cells were harvested approxi-
mately 48 h posttransfection. CAT activity was assayed
by a single phase extraction protocol (Seed and Sheen,
1988). Both luciferase and CAT assays used 25 ml cellu-
ar extract, and CAT assays were performed in duplicate.
b-Gal assays were performed by the modified 96-well
plate method using 50 ml of whole cell extractRosenthal, 1987). Sample absorbance was measured at
14 nm. A representative result of at least three experi-
ents is shown.
rimer extension assays
RNA used for primer extension experiments was har-
ested either from transiently transfected HeLa cells or
rom untransfected HuT-102 cells. Briefly, 60-mm dishes
f cells were lysed in guanidinium isothiocyanate solu-
ion [4 M guanidinium isothiocyanate, 20 mM sodium
cetate (pH 5.2), 0.1 mM DTT, 0.5% Sarkosyl]. Cell lysates
rom replica plates were pooled, sheared, and purified by
sCl gradient centrifugation. Single-stranded oligonucle-
tides were labeled with 32P to generate primer exten-
ion probes that were complementary to the non-coding
trand of the DNA at a site ;50 bases downstream of the
xpected transcription start site. Each assay used 10–20
mg of total RNA from HTLV-I LTR constructs in the pres-
ence of Tax. For LTR constructs in the absence of Tax,
80–100 mg of RNA was required to detect HTLV-I tran-
scripts. For each reaction, 32P-labeled oligo probe was
ybridized with an appropriate amount of RNA and ex-
ended using AMV reverse transcriptase (Promega).
roducts were analyzed on an acrylamide/urea se-
uencing gel. Primer extension reactions were per-
ormed in parallel with a sequencing reaction (Seque-
ase v2.0 DNA sequencing kit, Amersham) utilizing the
ame primer.
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